Cargando…

Gene Expression Profiling Reveals Epithelial Mesenchymal Transition (EMT) Genes Can Selectively Differentiate Eribulin Sensitive Breast Cancer Cells

OBJECTIVES: Eribulin mesylate is a synthetic macrocyclic ketone analog of the marine sponge natural product halichondrin B. Eribulin is a mechanistically unique inhibitor of microtubule dynamics. In this study, we investigated whether selective signal pathways were associated with eribulin activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dezső, Zoltán, Oestreicher, Judith, Weaver, Amy, Santiago, Stephanie, Agoulnik, Sergei, Chow, Jesse, Oda, Yoshiya, Funahashi, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149521/ https://www.ncbi.nlm.nih.gov/pubmed/25171249 http://dx.doi.org/10.1371/journal.pone.0106131

Ejemplares similares

Eribulin mesylate exerts specific gene expression changes in pericytes and shortens pericyte-driven capillary network in vitro
por: Agoulnik, Sergei I, et al.
Publicado: (2014)

Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states
por: Yoshida, T, et al.
Publicado: (2014)

Circulating miRNA Biomarkers for Alzheimer's Disease
por: Kumar, Pavan, et al.
Publicado: (2013)

Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study
por: Horimoto, Yoshiya, et al.
Publicado: (2018)

dbEMT: an epithelial-mesenchymal transition associated gene resource
por: Zhao, Min, et al.
Publicado: (2015)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer
por: O’Shannessy, Daniel J., et al.
Publicado: (2013)

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
por: Niwa, Yuki, et al.
Publicado: (2023)

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
por: Ho, Gwo Yaw, et al.
Publicado: (2022)

Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition (EMT), a Particular Case
por: Cebrià-Costa, Joan Pau, et al.
Publicado: (2014)

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
por: Ashrafizadeh, Milad, et al.
Publicado: (2020)

Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases
por: Sarrand, Julie, et al.
Publicado: (2023)

Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition
por: Kitahara, Hiroko, et al.
Publicado: (2016)

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
por: Funahashi, Yasuhiro, et al.
Publicado: (2014)

Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
por: Zvaifler, Nathan J
Publicado: (2006)

Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
por: Grant, Campbell M., et al.
Publicado: (2013)

Epithelial mesenchymal transition (EMT) in small airways of COPD patients
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

Quantifying the Epithelial-to-Mesenchymal Transition (EMT) from Bench to Bedside
por: Brown, Meredith S., et al.
Publicado: (2022)

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis
por: Marconi, Guya D., et al.
Publicado: (2021)

Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
por: Li, Dandan, et al.
Publicado: (2023)

MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
por: Ding, Xiang-Ming
Publicado: (2014)

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
por: Misra, Ashish, et al.
Publicado: (2012)

Effect of Cigarette Smoking on Epithelial to Mesenchymal Transition (EMT) in Lung Cancer
por: Vu, Trung, et al.
Publicado: (2016)

The Key Role of Epithelial to Mesenchymal Transition (EMT) in Hypertensive Kidney Disease
por: Seccia, Teresa, et al.
Publicado: (2019)

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
por: Du, Bowen, et al.
Publicado: (2016)

Is There an Interconnection between Epithelial–Mesenchymal Transition (EMT) and Telomere Shortening in Aging?
por: Imran, Siti A. M., et al.
Publicado: (2021)

The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma
por: Ramundo, Valeria, et al.
Publicado: (2021)

Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
por: Zhong, Weilong, et al.
Publicado: (2023)

Proteome Landscape of Epithelial-to-Mesenchymal Transition (EMT) of Retinal Pigment Epithelium Shares Commonalities With Malignancy-Associated EMT
por: Sripathi, Srinivasa R., et al.
Publicado: (2021)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2022)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD)
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2013)

The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing
por: Yin, Shu-Yi, et al.
Publicado: (2013)

Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis
por: Tennakoon, Anusha H., et al.
Publicado: (2015)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_halp1ijvrgcis6oqn6999cip57